Vijay Reddy, M.D., Ph.D

Vijay Reddy, M.D., Ph.D. has a diverse and extensive work experience. Vijay is currently serving as the Chief Medical Officer at D2V Clinical since February 2022. Prior to that, they held the position of Vice President of Clinical Development at Actinium Pharmaceuticals, Inc. from April 2018 to February 2022. Before that, they worked as a Senior Medical Director at Pharmacyclics from September 2016 to March 2018. Vijay also served as the Director of Oncology at MedImmune from August 2015 to September 2016 and as a Medical Director of Oncology at Janssen, Pharmaceutical Companies of Johnson and Johnson from March 2013 to July 2015. Additionally, they worked as a Medical Director at Florida Center for Cellular Therapy from July 2007 to January 2013 and held teaching positions as an Assistant and Associate Professor at the University of Florida from December 1998 to June 2007.

Dr. Vijay Reddy pursued a Fellowship at the Dana Farber Cancer Institute, Harvard Medical School from 1997 to 1998. No specific field of study is mentioned in the provided information.